SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 41, Issue 9, Pages 2324-2334
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1038/npp.2016.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial ofS-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder
- (2014) David Mischoulon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
- (2013) Pau Celada et al. CNS DRUGS
- Chronic SSRI Treatment Exacerbates Serotonin Deficiency in Humanized Tph2 Mutant Mice
- (2012) William B. Siesser et al. ACS Chemical Neuroscience
- l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
- (2012) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse
- (2012) J. P. R. Jacobsen et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Next-Generation Treatments for Mental Disorders
- (2012) T. R. Insel Science Translational Medicine
- Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice
- (2011) J P R Jacobsen et al. MOLECULAR PSYCHIATRY
- Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains
- (2011) Cristina S. Benton et al. PSYCHOPHARMACOLOGY
- Borderline personality disorder
- (2010) Falk Leichsenring et al. LANCET
- Analysis of Intact Glucuronides and Sulfates of Serotonin, Dopamine, and Their Phase I Metabolites in Rat Brain Microdialysates by Liquid Chromatography−Tandem Mass Spectrometry
- (2009) Päivi Uutela et al. ANALYTICAL CHEMISTRY
- Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
- (2009) Francisco Lopez-Munoz et al. CURRENT PHARMACEUTICAL DESIGN
- L-Methylfolate: A Vitamin for Your Monoamines
- (2009) Stephen M. Stahl JOURNAL OF CLINICAL PSYCHIATRY
- Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review
- (2008) R. Whale et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
- (2008) Lynette C. Daws PHARMACOLOGY & THERAPEUTICS
- Amino Acid Transport Across Mammalian Intestinal and Renal Epithelia
- (2008) Stefan Bröer PHYSIOLOGICAL REVIEWS
- Role of GSK3 in behavioral abnormalities induced by serotonin deficiency
- (2008) J.-M. Beaulieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice
- (2008) Meredith A. Fox et al. PSYCHOPHARMACOLOGY
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
- (2008) Irving Kirsch et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started